A leading Korean drug delivery and formulation company has dedicated to the development of technologically-advanced, economically-attractive, and value-added pharmaceutical products, mainly through various drug delivery and formulation technologies and experiences since established in 2002.
During the past 5 years the Company has been developing Artemisia-origined oral herbal product for the prevention and treatment of gastritis, which is a progressive inflammation disease in the stomach lining. It is caused by many factors such as excessive alcohol consumption, prolonged use of nonsteroidal anti-inflammatory drugs(NSAIDs), surgery, bacterial infection, stress and so on.
Artemisia asiatica has been frequently used in traditional Asian medicine for the treatment of diseases such as inflammation, cancer and microbial infection. Of the compositions extracted from Artmisia, eupatilin and jaceosidin are major bioactive flavones exhibiting various antioxidant, antiinflammatory, antibacterial, and antitumor activities. This Artemisiae herb extract tablet, showed outstanding preclinical and clinical efficacy as well as long-term safety usually regarded as better than chemical drugs.